Introduction {#Sec1}
============

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of chronic inflammatory joint conditions that can cause structural damage \[[@CR1]\]. Seven mutually exclusive subtypes of JIA are defined in the 2001 Edmonton classification developed by the International League Against Rheumatism (ILAR) \[[@CR2]\]. This classification has been challenged and modifications suggested, such as exclusion of systemic-onset JIA (sJIA) due to its similarity to autoinflammatory diseases \[[@CR3], [@CR4]\].

The prevalence of joint damage among patients with JIA has been estimated at 8--27 % in extended oligoarticular JIA (oJIA), 35--67 % in polyarticular JIA (pJIA) and up to 80 % in rheumatoid factor (RF)-positive pJIA \[[@CR5], [@CR6]\]. The main treatment objectives in JIA are to control the pain and to prevent structural damage. Joint space narrowing (JSN), bone erosions and demineralization are radiographic findings shared between JIA and adult rheumatoid arthritis (RA). Changes specific to the paediatric population are early growth plate closure, epiphyseal deformity and growth asymmetry \[[@CR7]\].

Conventional radiography (CR), magnetic resonance imaging (MRI) and ultrasound (US) are the imaging modalities most often used to evaluate joint inflammation or structural damage \[[@CR8]\]. MRI and US hold considerable promise but are still under evaluation in JIA. CR remains the most readily available imaging technique for detecting and monitoring structural damage. However, potential limitations of CR in JIA include the risk of radiation-induced harm to the patient, interpretation difficulties raised by skeletal immaturity, and the delayed development of structural joint damage. Furthermore, because JIA is rare, little is known about the potential effects of synthetic or biological disease-modifying anti-rheumatic drugs (DMARDs) on structural joint damage \[[@CR9]--[@CR11]\]. Thus, whereas recommendations based on large studies are available for the radiographic assessment of chronic inflammatory joint disease in adults \[[@CR12], [@CR13]\], no similar guidelines have been developed for JIA. A task force was recently convened by the European League Against Rheumatism (EULAR) -- Paediatric Rheumatology European Society (PReS) to develop recommendations about imaging studies for diagnosing and managing JIA \[[@CR14]\]. Although this undertaking acknowledged, for the first time, that an assessment of imaging studies in JIA was needed, the task force neither focussed on CR nor provided specific guidance for everyday practice.

We established a multidisciplinary task force to develop guidelines on the use of CR for the diagnosis and follow-up of each JIA subtype in everyday practice. Our project was supported by the French Society for Rheumatology (SFR), French Society for Paediatric Rheumatology and Internal Medicine (SOFREMIP), French Society for Paediatric and Prenatal Imaging (SFIPP), French Society for Radiology (SFR), and largest non-profit paediatric rheumatology patient organisation in France (KOURIR).

Methods {#Sec2}
=======

Field of research {#Sec3}
-----------------

We considered the following situations, at diagnosis and during follow-up, in each of the following five subtypes of JIA (oJIA, pJIA with and without RF and/or anti-citrullinated peptide antibody (ACPA), juvenile psoriatic arthritis (jPsA), and enthesitis-related arthritis (ERA)) Undifferentiated arthritis, as a heterogeneous subset related to one or several subtypes, and systemic JIA, having a peculiar articular course and structural prognosis, were left aside**.** Experts also focused on juvenile monoarthritis. Special attention was directed to the cervical spine, hip and temporo-mandibular joints (TMJs).

Recommendation development process {#Sec4}
----------------------------------

The task force comprised 16 JIA experts (eight rheumatologists, five paediatricians, two paediatric radiologists experienced in skeletal disease and one patient organisation representative). We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method \[[@CR15], [@CR16]\] for elaborating, evaluating, disseminating and implementing recommendations elaborated by the EULAR and the Outcome Measures in Rheumatology (OMERACT) group \[[@CR17], [@CR18]\], and the Population, Intervention, Comparison, Outcome (PICO) process to frame the research questions.

We considered structural radiographic abnormalities: JSN, erosions, pseudo-joint space widening for sacro-iliac joint \[[@CR19], [@CR20]\] and ankylosis \[[@CR12]\]. A research fellow (PM) assisted by two experts in systematic review methodology (CGV, methodologist; and VDP, convenor) performed a systematic literature review by searching PubMed, Scopus/Elsevier, and the Cochrane Library. Original articles including clinical trials, retrospective cohort studies, other retrospective studies, and case-control studies published between 1980 and December 2016 were identified. The following indexing was used: 'juvenile idiopathic arthritis' OR 'juvenile rheumatoid arthritis' OR 'juvenile chronic arthritis' OR 'juvenile psoriatic arthritis' OR 'enthesitis-related arthritis' OR 'juvenile spondyloarthritis' AND 'radiography' OR 'X-ray' (see Appendix [1](#MOESM1){ref-type="media"} for details). The quality of evidence and grades of recommendation were determined according to the standards of the Oxford Centre for Evidence-Based Medicine \[[@CR21]\]. Recommendations were graded A to D depending on the level of the underlying evidence (from 1A to 4) \[[@CR18]\].

The task force debated and formulated a preliminary set of recommendations based on the systematic literature review supplemented, when necessary, by their expert opinion. This set was then evaluated by a panel of 14 independent French-speaking experts. Modifications were debated by the task force. The final recommendations were then rated on a 10-point scale by the task force and independent panel through a Delphi process.

Results {#Sec5}
=======

Systematic literature review {#Sec6}
----------------------------

Of the 118 publications identified by the literature search, 74 \[[@CR5], [@CR6], [@CR9]--[@CR11], [@CR19], [@CR20], [@CR22]--[@CR88]\] original articles, as well as one abstract \[[@CR89]\] and one online recommendation \[[@CR90]\], were included (Fig. [1](#Fig1){ref-type="fig"}, Table [1](#Tab1){ref-type="table"}).Fig. 1.Systematic literature review flow-chartTable 1Details of the studies identified by the systematic literature reviewArticleDesignJIA subtypeNumber of patientsImaging findings used as outcomeImaging techniquePurposeMaldonado-Cocco 1980 \[[@CR46]\]ProspectiveJRA100PrimaryCRTo assess the frequency of carpal ankylosisWilliams and Ansell 1985 \[[@CR54]\]RetrospectiveRF+ pJIA81PrimaryCRTo assess peripheral radiographic progressionPoznanski 1991 \[[@CR26]\]Narrative reviewJRANANACRTo develop a first score for assessing radiographic damageHarel 1993 \[[@CR10]\]ProspectiveJRA23PrimaryCRTo assess effects of MTX on radiographic progression evaluated based on carpal lengthRavelli 1998 \[[@CR11]\]RetrospectivepJIA26PrimaryCRTo assess carpal length changes during MTX therapy in pJIA (with bilateral wrist involvement)Guillaume 2000 \[[@CR35]\]ProspectiveoJIA207SecondaryCRTo identify prognostic factors in oJIAAl-Matar 2002 \[[@CR36]\]RetrospectiveoJIA205SecondaryCRTo identify early features associated with poor outcome in oligoarticular-onset JIAFlatø 2002 \[[@CR30]\]RetrospectiveJRA, SEA, JPsA, IBD- associated arthritis314PrimaryCRTo assess factors associated with radiographic sacroiliitis in JIAHuemer 2002 \[[@CR64]\]ProspectiveJPsA, oJIA87NoNATo compare clinical features of JPsA and oJIA, including patterns of joint involvement, and to discuss classificationLaiho 2002 \[[@CR70]\]Cross-sectionalJCA159PrimaryCRTo evaluate radiographic inflammatory changes in the cervical spineMason 2002 \[[@CR49]\]Cross-sectionalPolyarticular JRA60PrimaryCRTo assess the frequency of in hand/wrist CR damage at diagnosisOen 2002 \[[@CR39]\]Narrative reviewJIANANANATo identify outcome predictors, including radiographic findingsBowyer 2003 \[[@CR40]\]RetrospectiveoJIA, pJIA, sJIA703SecondaryCRTo assess health status 1 and 5 years after disease onsetDoria 2003 \[[@CR45]\]Cross-sectionalJRA60PrimaryCRTo assess inter- and intra- observer variability of two scoring systems (Larsen/modified Larsen), comparison to MRIFlatø 2003 \[[@CR50]\]Case-controlJRA268SecondaryCRTo assess long-term prognostic factorsMagni-Manzoni 2003 \[[@CR51]\]ProspectivepJIA, extended oJIA, sJIA, JPsA, ERA94PrimaryCRTo assess the rate of radiographic progression (Poznanski score)Oen 2003 \[[@CR38]\]RetrospectiveJRA216PrimaryCRTo assess radiographic damage in early and advanced diseaseOen 2003 \[[@CR37]\]RetrospectiveJRA393SecondaryCRTo identify early predictors of long-term outcomeRavelli and Martini 2003 \[[@CR6]\]Narrative reviewAll subtypesNANANATo identify early predictors of outcomes, including radiographic outcomesTsitsami 2003 \[[@CR68]\]RetrospectiveoJIA, JPsA, UA185SecondaryCRTo evaluate associations between a familial history of psoriasis and the outcome of oligoarticular JIAVan Rossum 2003 \[[@CR31]\]ProspectivepJIA, oJIA, extended oJIA67PrimaryCRTo describe radiographic featuresTwilt 2004 \[[@CR73]\]Cross-sectionalJIA (all subtypes)97PrimaryCRTo evaluate the prevalence of radiographic damage on the OPGMason 2005 \[[@CR5]\]ProspectivePolyarticular JRA12PrimaryCRTo assess radiographic progression after 2 yearsVan Rossum 2005 \[[@CR29]\]ProspectivepJIA, oJIA66PrimaryCRTo assess sensitivity of Dijkstra radiographic scoreHelenius 2006 \[[@CR83]\]ProspectiveAdult: RA, AS, SPA, MCTD67PrimaryCR, MRITo describe clinical, radiographic and MRI findings in rheumatic diseasesRossi 2006 \[[@CR33]\]ProspectivepJIA25PrimaryCRTo assess the reliability of the Sharp and Larsen radiographic scoring systemsFlatø 2006 \[[@CR58]\]Case / controlERA/oJIA, pJIA55/55SecondaryCRTo compare clinical, functional and radiological features in ERA versus other JIA subtypesSelvaag 2006 \[[@CR28]\]ProspectivesJIA, pJIA, oJIA, ERA137PrimaryCRTo assess radiographic findings at diagnosis and 3-years laterBilliau 2007 \[[@CR82]\]ProspectivesJIA, RF+ and RF- pJIA, oJIA, ERA, JPsA100SecondaryCRTo describe clinical, orthodontic, OPG and lateral cephalogram in 46 patientsGilliam 2008 \[[@CR44]\]RetrospectiveRF+ and RF- pJIA, oJIA, sJIA68SecondaryCRTo evaluate associations of markers, including radiographic changes, to disease severityHabib 2008 \[[@CR47]\]Cross-sectionalpJIA, sJIA, oJIA68SecondaryCRTo determine the prevalence and significance of ACPAs in JIANielsen 2008 \[[@CR9]\]Retrospectiveextended oJIA, sJIA, pJIA, JPsA40PrimaryCRTo evaluate the radiographic outcome (Poznanski score) during etanercept therapyPedersen 2008 \[[@CR84]\]ProspectiveJIA (subtype not specified)15PrimaryCR, MRITo describe clinical, CRand MRI features; to compare CR to MRIRostom 2008 \[[@CR57]\]Cross-sectionalJIA (all subtypes)121PrimaryCRTo determine the prevalence of clinical and radiological hip involvementMüller 2009 \[[@CR77]\]ProspectiveJIA (all subtypes)30PrimaryUS, MRITo compare clinical examination/US to MRIButbul 2009 \[[@CR62]\]RetrospectiveJPsA, oJIA, pJIA106NoNATo compare clinical features in JPsA to other JIA subtypes with similar patterns of joint disease -- including growth abnormalitiesEndén 2009 \[[@CR71]\]Cross-sectionalsJIA, pJIA/ fibromyalgia (control)134/24PrimaryCRTo describe growth and cervical vertebrae size in JIA (vs. control)Flatø 2009 \[[@CR63]\]RetrospectiveJPsA, oJIA, pJIA336SecondaryCRTo compare JPsA features (including radiographic sacro-iliitis) and outcomes to other JIA subtypesLin 2009 \[[@CR60]\]Cross-sectionalJuvenile AS47 juvenile AS, 122 adult ASSecondaryCRTo compare clinical, laboratory and radiographic features between juvenile and adult-onset ASTafaghodi 2009 \[[@CR34]\]RetrospectiveJIA (all subtypes)174PrimaryCRTo assess radiographic characteristics of JIA (118 patients) vs. ALL (56 patients)Arvidsson 2010 \[[@CR76]\]ProspectiveJRA60PrimaryCR, CTTo assess TMJ imaging during follow-up for long-standing JIAPagnini 2010 \[[@CR20]\]ProspectiveERA59PrimaryCR, MRITo identify predictors of sacroiliitisStoll 2010 \[[@CR19]\]RetrospectiveERA, JSpA, JPsA143PrimaryCR, MRITo identify risk factors for sacroiliitisCannizzaro 2011 \[[@CR85]\]RetrospectiveoJIA, RF+ and RF- pJIA, JPsA, ERA, sJIA223SecondaryCR, MRITo determine the incidence of TMJ involvement in different JIA subtypesKjellberg 2011 \[[@CR72]\]Case-controlpJIA, oJIA, JPsA, ERA, UA82PrimaryCRTo compare radiographic cephalometry findings in JIA and healthy controlsRavelli 2011 \[[@CR24]\]RetrospectiveoJIA, RF- negative pJIA, JPsA, UA971SecondaryCRTo compare disease characteristics depending on ANA statusStoll 2011 \[[@CR65]\]RetrospectiveJPsA\
oJIA87/303NoNATo compare clinical features of oJIA vs. JPsAStoll 2011 \[[@CR66]\]Narrative reviewJPsANANoNATo identify features of JPsA, in comparison with other subtypes of JIABertilsson 2012 \[[@CR41]\]ProspectiveJCA132SecondaryCRTo prospectively investigate the characteristics and outcome predictors over 5 years of follow-upLipinska 2012 \[[@CR27]\]ProspectiveoJIA, pJIA, sJIA74SecondaryCRTo assess the Steinbrocker score depending on ACPA statusBertilsson 2013 \[[@CR42]\]ProspectiveJCA132SecondaryCRTo evaluate long-term outcomes, after 17 years of follow-upChen 2012 \[[@CR56]\]Cross-sectionalJuvenile- onset AS67SecondaryCRTo compare clinical, laboratory and radiographic features of juvenile-/adult-/late-onset ASOzawa 2012 \[[@CR52]\]Cross-sectionalpJIA, sJIA40SecondaryCRTo compare radiological and laboratory findings in pJIA and sJIAAbramowicz 2013 \[[@CR75]\]RetrospectiveJIA51PrimaryMRITo identify prevalence of synovitis on MRI, TMJ imagingand clinical predictive factorsElhai 2013 \[[@CR48]\]ProspectivepJIA43PrimaryCRTo compare radiological outcomes of pJIA at transition vs. matched RA patientsElhai 2013 \[[@CR69]\]Cross-sectionalpJIA/RA57/58PrimaryCRTo compare the frequency of cervical spine radiographic damage between long-standing pJIA and RAJadon 2013 \[[@CR59]\]Systematic reviewJuvenile-onset ASNANACRTo compare clinical, social and radiographic features of adult- vs. juvenile-onset ASOmar 2013 \[[@CR53]\]Cross-sectionaloJIA, pJIA, sJIA54SecondaryCRTo assess correlations linking ACPA presence to the JADAS and Sharp van der Heijde scoresCedströmer 2013\[[@CR78]\]RetrospectiveoJIA, sJIA, pJIA, JPsA, ERA266SecondaryCRTo describe clinical findings and disease activity and their associations with CR abnormalitiesGiancane 2014 \[[@CR43]\]ProspectiveRF+ and RF- pJIA, sJIA, extended oJIA, UA, JPsA186PrimaryCRTo assess radiographic outcomes during follow-up (1--10 years)Jaremko 2014 \[[@CR61]\]Cross-sectionalJuvenile AS26PrimaryCR, MRITo compare the usefulness of CR and MRI for sacro-iliac joint evaluation at diagnosis of juvenile ASRodriguez-Lozano 2014 \[[@CR32]\]Cross-sectionalsJIA, RF+ and RF- pJIA, JPsA, extended oJIA60 CRNACRTo assess the inter-observer reliability of CR interpretationAbramowicz 2014 \[[@CR74]\]RetrospectiveoJIA, pJIA, JPsA30PrimaryCR, MRITo identify radiographic findings associated with TMJ synovitis on MRIGórska 2014 \[[@CR79]\]Cross-sectionaloJIA, pJIA26PrimaryCRTo describe orthodontic and radiographic findingsKoos 2014 \[[@CR80]\]Case-controloJIA, RF- negative pJIA, ERA, JPsA/non-JIA controls23/23PrimaryCone Beam CTTo describe pathological changes in TMJsKoos 2014\[[@CR81]\]Cross-sectionalJIA (all subtypes)/controls134/134PrimaryMRITo evaluate the reliability of clinical symptoms for diagnosing TMJ synovitisRingold 2014 \[[@CR55]\]RecommendationspJIANANACRTo develop CARRA recommendations for treating new-onset pJIAColebatch-Bourn 2015 \[[@CR87]\]RecommendationsAll subtypesNANACR, US, MRIEULAR recommendations/ all imaging techniquesRavelli 2015 \[[@CR23]\]Narrative reviewJPsANANANoTo assess the classification of JPsA and its relation to oJIAChan 2016 \[[@CR22]\]ProspectiveJPsA and non-psoriatic JIA57NoNoTo discuss the classification of JPsAJadon 2016 \[[@CR88]\]ProspectiveAdult AS and PsA402PrimaryCRTo compare radiographic features of AS vs. PsA with axial diseaseKavanaugh 2016\[[@CR25]\]Phase III clinical trialAdult PsA405PrimaryCRTo assess the efficacy of golimumab on radiographic progression in adult PsAKristensen 2016 \[[@CR86]\]Systematic reviewAll subtypesNANAMRITo identify clinical predictors of TMJ involvement, needing imaging assessmentWeiss 2016 \[[@CR67]\]ProspectiveJSpA40PrimaryCR, MRITo evaluate the prevalence of sacroiliitis, compared to physical examination findingsGuide du bon usage des examens d'imagerie (French online recommendation) \[[@CR90]\]RecommendationsNANANACRTo develop recommendations about CR for focal limb painRavelli 2014 \[[@CR89]\] (ACR Pediatric Rheumatology Symposium)Clinical trialpJIA87PrimaryCRTo assess the effect of tocilizumab on pJIA after 2 years, using the van der Heijde and Poznanski scores*ACPA* anti-citrullinated protein antibody, *ALL* acute lymphoblastic leukaemia, *ANA* antinuclear antibody, *AS* ankylosing spondylitis, *CARRA* Childhood Arthritis and Rheumatology Research Alliance, *CR* conventional radiography, *IBD* inflammatory bowel disease, *JADAS* Juvenile Arthritis Disease Activity Score, *JCA* juvenile chronic arthritis (former EULAR criteria), *JRA* juvenile rheumatoid arthritis (former ACR criteria), *JPsA* juvenile psoriatic arthritis, *JSpA* juvenile spondyloarthritis, *MCTD* mixed connective tissue disease, *MTX* methotrexate, *NA* not applicable, *oJIA* oligoarticular juvenile idiopathic arthritis, *OPG* orthopantomogram, *pJIA* polyarticular juvenile idiopathic arthritis, *SEA* seronegative enthesopathy and arthropathy, *sJIA* systemic juvenile idiopathic arthritis, *UA* undifferentiated arthritis

Recommendations {#Sec7}
---------------

The experts elaborated four overarching principles and 31 recommendations. Table [2](#Tab2){ref-type="table"} lists the recommendations.Table 2Recommendations about CR as a diagnostic and follow-up investigation in non-systemic JIA, with scores for agreement among experts, levels of evidence and gradeRecommendationsMean agreement score (±SD)Level of evidenceGrade*Overarching principles* A. A CR assessment is necessary in JIA.9.30 (±1.26)\-- B. The potential risks associated with exposure to ionising radiation must always be considered when using CR.9.70 (±0.70)\-- C. CR is difficult to interpret in skeletally immature patients, particularly those \<5 years of age.8.95 (±1.73)\-- D. Other imaging techniques, such as US and MRI, are being developed in JIA, and will be discussed in specific recommendations.8.95 (±1.85)\--*Oligoarthritis (oJIA)* 1. CR should not be performed routinely as a diagnostic investigation.8.20 (±1.94)3C 2 During follow-up, CR should be performed on affected joint(s) that remain symptomatic\* after 3 months9.10 (±2.17)4D 3. In patients with persistently symptomatic\* joints, the reiteration of CR during follow-up is at the discretion of the physician.9.1 5(±1.04)4D 4. In patients with inactive disease, CR is not recommended.9.45 (±0.83)4D 5. In patients with extended oJIA, the recommendations for pJIA should be applied.9.30 (±0.92)3C 6. In patients with structural damage, the selection and timing of specific imaging techniques to further assess the damaged joint during follow-up is guided by clinical considerations.9.15 (±1.04)4D*Polyarthritis (pJIA)* 7. Routine CR of the wrists, hands, and forefeet is strongly recommended at the diagnosis of polyarticular JIA with positive RF/ACPA.9.30 (±1.26)2B, 3B 8. CR of other joints than wrists, hands, and forefeet, is recommended at the diagnosis for symptomatic\* joints only.9.00 (±1.49)2B,3B 9. In new-onset RF/ACPA-negative pJIA with adverse prognostic factors, CR at diagnosis should be performed as for RF/ACPA-positive pJIA (recommendation \#7).8.55 (±2.46)3C 10. Adverse prognostic factors are early wrist involvement, distal involvement, symmetric arthritis, high CRP/ESR, and bone erosions.9.35 (±0.81)2BB 11. In new-onset, RF/ACPA-negative pJIA without adverse prognostic factors, at diagnosis, CR should be confined to symptomatic\* joints.8.15 (±2.28)4D 12. In RF/ACPA-positive pJIA, CR of the hands, wrists, and forefeet is strongly recommended8.6 (±1.31)2A, 2BB  - 1 year after disease onset8.30 (±1.72)2BB  - and when transitioning from paediatric to adult healthcare8.85 (±0.99)4D  At other time points, the use of CR during follow-up is at the discretion of the physician.9.25 (±0.85)4D 13. Routine CR of other joints is not recommended.9.40 (±0.75)4D 14. During the follow-up of RF/ACPA-negative pJIA with adverse prognostic factors, CR should be performed as for RF/ACPA-positive pJIA (recommendation \#12).9.00 (±2.03)3C 15. During the follow-up of RF/ACPA-negative pJIA without adverse prognostic factors, the use of CR is at the discretion of the physician.9.50 (±1.17)4D 16. CR can be repeated in patients who remain symptomatic longer than 3 months.8.25 (±2.10)4D 17. In patients with structural damage, the selection and timing of specific imaging techniques during follow-up is guided by clinical considerations.9.35 (±0.81)4D*Enthesitis-related arthritis (ERA)* 18. In patients with axial ERA, CR of the spine and hip joints should be performed only when needed for the differential diagnosis.8.05 (±2.42)4D 19. During the follow-up of axial ERA, CR should be considered only for the hip joints, depending on the clinical course and availability of US and/or MRI.8.90 (±1.33)3C 20. CR is not recommended for multifocal enthesitis.9.10 (±0.97)4D 21. In patients with isolated enthesitis, CR can be considered as a tool for establishing the differential diagnosis.8.35 (±2.43)4D*Psoriatic arthritis (jPsA)* 22. No specific recommendation can be made about CR in juvenile psoriatic arthritis.9.20 (±0.83)4D 23. Guidance may be taken from the recommendations above, depending on the clinical presentation, or from recommendations issued for adults.9.35 (±0.74)4D*Situations of specific interest* *Monoarthritis*  24. At the diagnosis of acute monoarthritis, CR of the involved joint should be performed, with two perpendicular views.9.35 (±1.04)3C  25. At the diagnosis of acute monoarthritis, comparative CR of the contralateral joint is unnecessary.8.50 (±2.39)4D  26. In patients with persistent neck pain related to JIA, MRI is preferable over CR.9.60 (±0.68)4D  27. When MRI is unavailable, CR is recommended only for the cervical spine and should consist only in a lateral view.8.80 (±1.56)4D  28. In patients with JIA who have neurological symptoms of spinal cord compression and neck pain, cervical MRI must be performed, on an emergency basis.9.80 (±0.52)3C  29. CR of the TMJs is not recommended when cross-sectional imaging is available.9.20 (±1.47)3C  30. Routine CR of the hip joint is not recommended in patients with pJIA.9.25 (±1.02)3C  31. When CR of a symptomatic hip joint is performed, a single view should be obtained, i.e., either an antero-posterior view or a frog leg view.9.05 (±1.28)4D*JIA* juvenile idiopathic arthritis, *CR* conventional radiography, *oJIA* oligoarticular juvenile idiopathic arthritis, *pJIA* polyarticular juvenile idiopathic arthritis, *RF* rheumatoid factor, *ACPA* anti-citrullinated protein antibody, *ERA* enthesitis-related arthritis, *TMJ* temporo-mandibular joint\*Symptomatic joints: swollen and/or painful joints, and/or joints with motion range limitation

Overarching principles {#Sec8}
----------------------

Radiation exposure was taken into account (principle B), according to French Society for Radiology recommendations \[[@CR90]\] (Appendix [2](#MOESM2){ref-type="media"}). Much of the cartilage is still radio-transparent in children younger than 5 years of age. In this age group, the need for CR must be evaluated with great care (principle C) \[[@CR91]\].

Other imaging modalities such as US and MRI are increasingly used in JIA. Although promising, they are not discussed herein. They will be the focus of specific recommendations (principle D).

### Oligoarticular JIA (oJIA) {#Sec9}

1\. *CR should not be performed routinely as a diagnostic investigation in oJIA*. The literature review identified ten studies in which CR was performed, even in patients younger than 4 years. Among them, one focussed specifically on oJIA \[[@CR35]\] and nine investigated several JIA subtypes but reported data separately for oJIA \[[@CR6], [@CR24], [@CR27], [@CR36]--[@CR38], [@CR40], [@CR42], [@CR43]\]. The usefulness of CR is limited by the incomplete ossification of the epiphyses, most notably in the youngest age groups \[[@CR33]\]. Therefore, when the diagnosis is definitive, CR is not recommended.

2\. and 3. During follow-up, CR should be performed on affected joint(s) that remain symptomatic after 3 months. By 'symptomatic joints'\*, we mean painful and/or swollen joints and/or joints that are limited in motion. In patients with persistently symptomatic\* joints, the reiteration of CR during follow-up is at the discretion of the physician. Several studies showed evidence of radiographic progression early in the natural history of oJIA \[[@CR24], [@CR27], [@CR35], [@CR38]\].

4\. *In patients with clinically inactive disease (CID), CR should not be performed routinely*. The diagnosis of CID relies on physician judgement, aided by validated tools \[[@CR92]--[@CR94]\]. No data are available on radiographic disease progression in clinically silent joints in patients with oJIA.

5\. *In patients with extended oJIA, the recommendations for pJIA should be applied.* The number of affected joints is strongly associated with structural damage in oJIA \[[@CR35]\].

6\. *In patients with structural damage, the selection and timing of specific imaging techniques to further assess the damaged joint during follow-up is guided by clinical considerations.*

Joints with structural damage must undergo specific CR evaluations during the patient's growth.

### Polyarticular JIA (pJIA) {#Sec10}

7\. and 8. *Routine CR of the wrists, hands and forefeet is strongly recommended at the diagnosis of polyarticular JIA with positive RF/ACPA. CR of other joints than wrists, hands and forefeet, is recommended at the diagnosis for symptomatic joints\*only.* Prospective studies were reviewed, with special attention to early pJIA. Erosions and JSN occurred preferentially at the hands, wrists and feet \[[@CR11], [@CR31], [@CR43], [@CR48]--[@CR51]\], joints that were sometimes asymptomatic \[[@CR31]\] CR at the diagnosis provides a reference for assessing disease progression. It is supported by 'adult' recommendations \[[@CR13]\] for rheumatoid arthritis, which has a similar structural evolution.

9\. and 10. *In new-onset RF/ACPA-negative pJIA with adverse prognostic factors, CR at diagnosis should be performed as for RF/ACPA-positive pJIA.* Box 1 lists the factors of adverse prognostic significance in pJIA \[[@CR31], [@CR44], [@CR50], [@CR51]\]. These factors are associated with a pattern of joint damage over time similar to that seen in RF/ACPA-positive pJIA \[[@CR38]\].

Box 1: Factors of adverse prognostic significance in polyarticular juvenile idiopathic arthritis (pJIA)Early involvement of wrists\
Symmetric arthritis\
Distal, small-joint arthritis\
Elevated ESR/CRP\
Pre-existing radiographic\
abnormalities

ESR, erthrocyte sedimentation rate; CRP, serum C-reactive protein level

11\. *In new-onset, RF/ACPA-negative pJIA without adverse prognostic factors, at diagnosis, CR should be confined to symptomatic\* joints*. This recommendation is based on expert opinion.

12\. *In RF/ACPA-positive pJIA, CR of the hands, wrists and forefeet is strongly recommended 1 year after disease onset, and when transitioning from paediatric to adult healthcare. At other time points, the use of CR during follow-up is at the discretion of the physician.* Prospective studies found evidence of joint damage even in asymptomatic joints \[[@CR31]\]. Patients with long-standing disease had high prevalences of joint erosions (30--70 % in historical studies) \[[@CR5], [@CR28], [@CR38], [@CR40], [@CR44], [@CR48], [@CR54]\], close to those in adults with RA \[[@CR48]\]. In RA, joint destruction at asymptomatic sites is a major predictor of adverse outcomes \[[@CR13], [@CR95]\]. However, radiographic progression with erosions in asymptomatic joints is not well documented in JIA and may have been underestimated. In a study of 471 joints in 67 patients with polyarticular JIA, radiographs showed erosions at the hands and feet in 36 % and 39 % of cases, respectively \[[@CR31]\]. Our literature review identified some data on the best times for CR. One study suggested a higher risk of radiographic progression within the first year after disease onset \[[@CR51]\]. The experts felt that CR contributed to ease the transition from paediatric to adult healthcare \[[@CR96]\].

13\. *Routine CR of other joints is not recommended***.** No data were found on which to base specific recommendations.

14\. *During the follow-up of RF/ACPA-negative pJIA with adverse prognostic factors, CR should be performed as for RF/ACPA-positive pJIA* (see recommendation \#12).

15\. *During the follow-up of RF/ACPA-negative pJIA without adverse prognostic factors, the use of CR is at the discretion of the physician****.*** No scientific data were available on which to base specific recommendations.

16\. and 17. *CR can be repeated in patients who remain symptomatic\* longer than 3 months. In patients with structural damage, the selection and timing of specific imaging techniques during follow-up is guided by clinical considerations*. The experts emphasised the need for careful attention to joints with active disease. In prospective studies, the time interval separating CR assessments of the same joints ranged from 8 months to 24 years. The 3-month interval in this recommendation was based on expert opinion.

### Enthesitis-related arthritis (ERA) {#Sec11}

18\. In patients with axial ERA, CR of the spine and hip joints should be performed only when needed for the differential diagnosis. Axial manifestations may arise at the spine, hips and sacro-iliac joints. A radiographic view specifically designed to assess the sacro-iliac joints is not recommended, as the results are not interpretable in skeletally immature patients and radiation exposure is significant \[[@CR20]\]. In patients with axial inflammatory pain, MRI (for both sacro-iliac and hip joints) and US (for the hip joint) may be more relevant \[[@CR67]\].

19\. *During the follow-up of axial ERA, CR should be considered only for the hip joints, depending on the clinical course and availability of US and/or MRI*. ERA is associated with a high prevalence of hip joint arthritis \[[@CR30], [@CR56], [@CR58]--[@CR60]\]. MRI or US are non-irradiating methods capable of detecting hip joint effusion; in addition, MRI can detect bone oedema. Therefore, in the future, MRI and US may deserve consideration as first-line imaging techniques. CR, however, is appropriate for monitoring known structural damage and deformities.

20\. and 21. *CR is not recommended for multifocal enthesitis. In patients with isolated enthesitis, CR can be considered as a tool for establishing the differential diagnosis.* When isolated enthesitis is suspected, CR may contribute to the differential diagnosis (e.g. with post-traumatic changes or osteochondritis); otherwise, CR is unhelpful for assessing peri-articular manifestations.

### Psoriatic juvenile arthritis (jPsA) {#Sec12}

22\. *No specific recommendation can be made about CR in juvenile psoriatic arthritis.* Scientific data are scarce \[[@CR62]--[@CR66], [@CR68]\]. The definition of this entity is still debated \[[@CR68]\]. Traditionally, two subtypes are described, an axial inflammatory disease resembling axial ERA and a peripheral joint disease resembling oJIA \[[@CR66]\].

23\. Guidance may be taken from the recommendations above, depending on the clinical presentation, or from recommendations issued for adults.

### Situations of specific interest {#Sec13}

#### Monoarthritis {#FPar1}

24\. *At the diagnosis of acute monoarthritis, CR of the involved joint should be performed, with two perpendicular views*. The French Society for Radiology \[[@CR90]\] strongly recommends CR of any site of focal bone pain in paediatric patients, with the goal of excluding a tumour, osteomyelitis, or a haematological malignancy \[[@CR34], [@CR97]\].

25\. *At the diagnosis of acute monoarthritis, comparative CR of the contralateral joint is unnecessary*. Because cartilage thickness varies within individuals, comparison to the healthy contra-lateral joint is uninformative \[[@CR26], [@CR33]\].

#### Cervical spine {#FPar2}

26\. *In patients with persistent neck pain related to JIA, MRI is preferable over CR*.

27\. *When MRI is unavailable, CR is recommended only for the cervical spine and should consist only of a lateral view.*

28\. *In patients with JIA who have neurological symptoms of spinal cord compression and neck pain, cervical MRI must be performed, on an emergency basis*.

In a cohort study of oJIA, 2.4 % of patients had cervical spine damage at the diagnosis \[[@CR35]\]. Cervical spine erosions and ankylosis are common in advanced pJIA \[[@CR42], [@CR71]\]. Evidence-based data are too scarce to recommend any specific pattern of radiological follow-up. Atlanto-axial diastasis may be normal in paediatric patients, and dynamic CR is therefore irrelevant. MRI is the most sensitive imaging technique, and is mandatory when spinal cord compression is suspected \[[@CR98]\].

#### Temporomandibular joints {#FPar3}

29\. *CR of the TMJs is not recommended when cross-sectional imaging is available*.

TMJ damage is common in JIA, with the prevalence ranging across studies from 17 % to 87 % \[[@CR73]\]. The TMJ cartilage is thin and condylar erosions therefore develop early. The panoramic radiograph is often normal at disease onset. Cross-sectional imaging offers better diagnostic performance. Imaging of the TMJs is not usually performed on a routine basis but is required in the event of pain, mouth-opening limitation or audible cracking of the TMJs \[[@CR74], [@CR76]--[@CR81], [@CR83], [@CR84]\]. MRI is considered the best imaging technique, although distinguishing the normal appearance from abnormal changes can be challenging \[[@CR99], [@CR100]\]. Cone-beam computed tomography allows three-dimensional reconstructions \[[@CR101]\]. The usefulness of US TMJ imaging is under debate \[[@CR77], [@CR102]\].

#### Hip joint {#FPar4}

30\. *Routine CR of the hip joint is not recommended in patients with pJIA.*

31\. *When CR of a symptomatic hip joint is performed, a single view should be obtained, i.e. either an antero-posterior view or a frog leg view.*

In RF/ACPA-positive pJIA, hip joint damage is common \[[@CR48]\] but CR of the hip joint is associated with a high level of ionising radiation exposure, so the hip is not among the joints for which routine CR is recommended .When available, MRI should be performed instead of, or in addition to, CR. If CR is performed, either an antero-posterior or a frog leg view is recommended, to visualise both hip joints and to allow the detection of bone erosions and/or avascular necrosis.

Discussion {#Sec14}
==========

CR is the most widely available imaging procedure worldwide. In paediatric patients, this advantage should be weighed against the heightened risks of radiation exposure and difficulty in interpreting joint radiographs before skeletal maturity is achieved. In addition, in JIA, radiographically visible joint damage takes time to develop, limiting the usefulness of CR. Specific recommendations about CR in paediatric patients are therefore needed, a fact that prompted the present work.

Obstacles to the development of recommendations about CR in JIA included the paucity of strong evidence about structural disease progression in JIA and the pooling of JIA subtypes in many studies. The low incidence of JIA contributes to explain the dearth of data. To maximise the usefulness of our recommendations to all physicians caring for patients with JIA, we focussed on CR and separated the five non-systemic, non-undifferentiated subtypes of JIA. Importantly, these recommendations are based not only on recently published data, but also, in many cases, on expert opinion, due to the paucity of paediatric studies. As a result, many of our recommendations are low grade, and in some cases obtaining guidance from recommendations for adults would seem to be the only option. However, the level of agreement among the multidisciplinary experts sitting on our panel was high.

Structural damage requires evaluation in JIA, especially in pJIA and extended oJIA, which carry the highest risk of adverse outcomes. In the treatment plans for pJIA developed by the CARRA, CR changes are considered an important outcome and their yearly assessment is suggested \[[@CR55]\]. However, the risk associated with exposure to ionising radiation during CR is of major concern, as pointed out by the representative of the patient organisation during our study. Little evidence is available on which to base an objective quantification of this risk. Our experts considered that the risk was substantial for CR of the pelvis and lumbar spine but was too small at peripheral sites to constitute an argument against using CR. To minimise radiation exposure, the experts recommended having CR performed at centres with expertise in paediatric radioprotection.

Research is needed in a broad range of areas to fill the knowledge gaps we identified when developing our recommendations (Box 2). More specifically, most paediatric clinical trials failed to assess potential treatment effects on structural damage. Also, data on structural damage just before the transition to adult healthcare are needed, since treatment recommendations for adults are based on structural damage.

Box 2: Research agenda- Follow-up of a cohort of patients with recent-onset RF/ACPA-positive polyarticular JIA, with annual CR for 10 years to identify predictors of structural joint damage\
- Comparison of radiographic disease progression in oligoarticular JIA in patients with and without antinuclear antibodies\
- Comparison of joint MRI, US, and CR as tools for detecting structural damage in patients younger than 5 years of age\
- Evaluation of joint damage at the transition from paediatric to adult healthcare in each JIA subtype\
- Improvement of the definition of juvenile psoriatic arthritis, to obtain homogeneous populations for studies of imaging techniques

We considered neither MRI nor US, both of which are under evaluation in JIA. Both are non-irradiating, and US is also widely available and inexpensive, although it requires specific training. US is now performed almost routinely in adults with joint disease. In paediatric patients, however, differentiating normal from abnormal findings by MRI and US can be challenging \[[@CR100], [@CR103]\]. Furthermore, very few physicians are specifically trained in paediatric US. The OMERACT and Health-e-Child Radiology groups are currently working together to standardise MRI protocols and interpretation in JIA \[[@CR104]--[@CR106]\].

In conclusion, CR still appears relevant in many situations in patients with JIA. CR is a widely available and inexpensive investigation that has an acceptable safety profile and can provide essential information about the structural course of the disease. Until validation studies of other imaging techniques, such as MRI and US, are completed, CR will remain the investigation of reference for assessing structural joint damage in patients with JIA.
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ACPA

:   Anti-Citrullinated Protein Antibody

CR

:   Conventional radiography

DMARDs

:   Disease-modifying Antirheumatic drugs

ERA

:   Enthesitis-related arthritis

EULAR

:   European League Against Rheumatism

GRADE

:   Grading of Recommendations, Assessment, Development and Evaluation

ILAR

:   International League Against Rheumatism

JIA

:   Juvenile idiopathic arthritis

jPsA

:   Juvenile psoriatic arthritis

JSN

:   Joint space narrowing

MRI

:   Magnetic resonance imaging

oJIA

:   Oligoarticular juvenile idiopathic arthritis

OMERACT

:   Outcome Measures in Rheumatology

PReS

:   Paediatric Rheumatology European Society

PICO

:   Population, Intervention, Comparison, Outcome

pJIA

:   Polyarticular juvenile idiopathic arthritis

RA

:   Rheumatoid arthritis

RF

:   Rheumatoid factor

SFIPP

:   French Society for Paediatric and Prenatal Imaging

SFR

:   French Society for Radiology

SFR

:   French Society for Rheumatology

sJIA

:   Systemic juvenile idiopathic arthritis

SLR

:   Systematic literature review

SOFREMIP

:   French Society for Paediatric Rheumatology and Internal Medicine

TMJ

:   Temporo-mandibular joint

US

:   Ultrasound
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